These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11122073)

  • 21. Paclitaxel hypersensitivity reactions: a role for docetaxel substitution.
    Lokich J; Anderson N
    Ann Oncol; 1998 May; 9(5):573. PubMed ID: 9653501
    [No Abstract]   [Full Text] [Related]  

  • 22. Docetaxel.
    Aikin JL
    Clin J Oncol Nurs; 1999 Apr; 3(2):83-4. PubMed ID: 10633618
    [No Abstract]   [Full Text] [Related]  

  • 23. Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. Clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel.
    Menges M; Pees HW
    Int J Pancreatol; 1999 Dec; 26(3):193-9. PubMed ID: 10732297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docetaxel (Taxotere): a new anti-cancer drug with promising potential?
    Verweij J
    Br J Cancer; 1994 Aug; 70(2):183-4. PubMed ID: 7914419
    [No Abstract]   [Full Text] [Related]  

  • 25. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
    Autier J; Picard-Dahan C; Marinho E; Grossin M; Yeni P; Leport C; Vildé JL; Crickx B; Descamps V
    Br J Dermatol; 2005 May; 152(5):1026-9. PubMed ID: 15888164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel as first- or second-line treatment for HIV-negative Kaposi's sarcoma: a retrospective study of 58 patients.
    Tourlaki A; Germiniasi F; Rossi LC; Veraldi S; Brambilla L
    J Dermatolog Treat; 2020 Mar; 31(2):183-185. PubMed ID: 30897011
    [No Abstract]   [Full Text] [Related]  

  • 27. Paclitaxel and docetaxel. Innovation, but at what cost?
    Lønning PE
    Pharmacoeconomics; 1995 Jul; 8(1):1-4. PubMed ID: 10155597
    [No Abstract]   [Full Text] [Related]  

  • 28. Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report.
    Anderson MA; Ying T; Wyburn K; Ferguson PM; Strach MC; Grimison P; Chadban S; Gracey DM
    BMC Urol; 2021 Jun; 21(1):87. PubMed ID: 34098936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of thrombocytopenia due to marrow metastases of breast cancer with weekly docetaxel.
    Ballot J; McDonnell D; Crown J
    J Natl Cancer Inst; 2003 Jun; 95(11):831-2. PubMed ID: 12783943
    [No Abstract]   [Full Text] [Related]  

  • 30. Inflammation of seborrheic keratoses due to docetaxel treatment.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(4):316-7. PubMed ID: 11720193
    [No Abstract]   [Full Text] [Related]  

  • 31. Docetaxel.
    Leahy M; Howell A
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):141-4. PubMed ID: 9166374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An expanding role for docetaxel.
    Hortobagyi G
    Semin Oncol; 1998 Dec; 25(6 Suppl 13):1-3. PubMed ID: 9865684
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel.
    Engin H; Celik I
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):178. PubMed ID: 12069127
    [No Abstract]   [Full Text] [Related]  

  • 34. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
    Silvestris N; Galetta D; Colucci G
    Anticancer Res; 2009 Feb; 29(2):675-6. PubMed ID: 19331220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Docetaxel symposium].
    Viens P
    Bull Cancer; 1997 Aug; 84(8):833-4. PubMed ID: 9339190
    [No Abstract]   [Full Text] [Related]  

  • 37. Taxing the taxanes: overused or undersold?
    Miller M
    J Natl Cancer Inst; 1999 Dec; 91(24):2077-8. PubMed ID: 10601377
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of iatrogenic Kaposi's sarcoma with low-dose docetaxel therapy.
    Yamashiro A; Awazawa R; Ohira A; Hirata T; Zamami R; Miyagi T; Takahashi K
    J Dermatol; 2018 Apr; 45(4):e96-e97. PubMed ID: 29215145
    [No Abstract]   [Full Text] [Related]  

  • 39. Conclusion: the place of docetaxel (Taxotere) in future therapy.
    Khayat D
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():53. PubMed ID: 8862713
    [No Abstract]   [Full Text] [Related]  

  • 40. Docetaxel (Taxotere): a highly active taxoid with manageable toxicity.
    Aapro MS
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):1-2. PubMed ID: 7740325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.